Understanding how certain brain receptors affect visual processing
Official title: Probing D2 and 5HT-2A mechanisms in early visual processing in V1
Funded at Duke University · NIH-11000271 · Data updated 2026-11-12
This study is looking at how certain brain receptors might affect how people with schizophrenia see things, with the goal of finding new ways to help improve their vision.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $78,892 |
| NIH project number | 5F32EY034772-03 |
| Project ID | NIH-11000271 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with schizophrenia who experience visual processing difficulties.
✕Less likely to help
Patients without visual processing deficits or those not diagnosed with schizophrenia may not benefit from this research.
What this research studies
This research investigates the role of specific brain receptors, particularly dopamine D2 and serotonin 5HT-2A, in how the brain processes visual information. It focuses on the primary visual cortex (V1) and aims to understand how these receptors contribute to visual deficits observed in conditions like schizophrenia. By examining the differences in how these receptors influence visual pathways, the research seeks to uncover potential therapeutic targets for improving visual processing in affected patients. The approach includes analyzing existing clinical data and exploring the effects of antipsychotic medications on visual processing.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for visual processing deficits in patients with schizophrenia and potentially other conditions.
How similar studies have gone: Previous research has shown that targeting dopamine and serotonin systems can improve visual deficits in schizophrenia, indicating a promising avenue for this investigation.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Galvin, Veronica — Duke University
- Study coordinator: Galvin, Veronica
Related research
Other NIH-funded projects on the same topics.
-
Investigating genetic factors in Lewy body diseases
This study is looking at how changes in a specific gene might play a role in conditions like Parkinson's disease and dementia, so that people can better understand how their genetics affect their health and possibly find more tailored treatments.
-
Targeting the PAX3-FOXO1 protein in a deadly childhood cancer
This study is looking at a specific protein that helps a tough childhood cancer called alveolar rhabdomyosarcoma, with the goal of finding new ways to treat kids who have this illness.
-
Improving population health by studying reproduction and development
This study is looking at how different things in our environment can impact pregnancy and the health of babies, and it’s for people who are planning to have children or are already parents, as it aims to help improve understanding and outcomes for everyone involved.
-
Modeling axon degeneration in C. elegans to help ALS patients
Researchers are using a tiny worm model to uncover how axons break down, which could point to new ways to help people with ALS and related nerve diseases.
-
Induced Suppression of Platelet Activity in Aneurysmal SAH Management
A new approach tests whether carefully reducing platelet activity can improve outcomes after aneurysmal subarachnoid hemorrhage.
-
AI-enhanced virtual reality tool to support remote emergency brain surgery training in Tanzania
A new AI-powered virtual reality tool helps non-experts in low-resource areas get real-time remote guidance for emergency traumatic brain injury surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.